Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
4,09 USD | +2,51% | +10,54% | +44,01% |
28/03 | Transcript : Humacyte, Inc. - Special Call | |
22/03 | Transcript : Humacyte, Inc., Q4 2023 Earnings Call, Mar 22, 2024 |
Attività
Numero di dipendenti: 184
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Laura Niklason
FOU | Founder | 61 | 13/10/04 |
Dale Sander
DFI | Director of Finance/CFO | 64 | 26/08/21 |
Shamik Parikh
CTO | Chief Tech/Sci/R&D Officer | 51 | 05/04/22 |
Heather Prichard
COO | Chief Operating Officer | 46 | 26/08/21 |
Yang Cao
LAW | General Counsel | 58 | 20/09/22 |
Sabrina Osborne
HRO | Human Resources Officer | - | - |
Corporate Officer/Principal | 53 | 26/08/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Gordon Binder
BRD | Director/Board Member | 88 | 26/08/21 |
Brady Dougan
BRD | Director/Board Member | 64 | 26/08/21 |
Laura Niklason
FOU | Founder | 61 | 13/10/04 |
Max Wallace
BRD | Director/Board Member | 72 | 26/08/21 |
Director/Board Member | 61 | 26/08/21 | |
Director/Board Member | 49 | 26/08/21 | |
Director/Board Member | 74 | 26/08/21 | |
Chairman | 74 | 26/08/21 | |
Emery Brown
BRD | Director/Board Member | 67 | 26/08/21 |
Charles Green
BRD | Director/Board Member | 68 | 15/09/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 119 083 728 | 81 643 306 ( 68,56 %) | 0 | 68,56 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+44,01% | 487 Mln | |
+1,77% | 42,86 Mrd | |
+45,94% | 41,36 Mrd | |
+12,24% | 42,74 Mrd | |
-8,83% | 27,68 Mrd | |
+7,44% | 25,15 Mrd | |
-23,01% | 18,63 Mrd | |
+30,56% | 12,37 Mrd | |
-1,82% | 11,92 Mrd | |
+8,35% | 11,21 Mrd |
- Borsa valori
- Azioni
- Azione HUMA
- Società Humacyte, Inc.